<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-09-24</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Alterations within the tryptophan-kynurenine metabolic pathway have been linked to the etiology of colorectal cancer (CRC), but the relevance of this pathway for prognostic outcomes in CRC patients needs further elucidation. Therefore, we investigated associations between circulating concentrations of tryptophan-kynurenine pathway metabolites and all-cause mortality among CRC patients. This study utilizes data from 2102 stage I-III CRC patients participating in six prospective cohorts &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308505/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">The past, present, and future of the brain imaging data structure (BIDS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308505-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Brain Imaging Data Structure (BIDS) is a community-driven standard for the organization of data and metadata from a growing range of neuroscience modalities. This paper is meant as a history of how the standard has developed and grown over time. We outline the principles behind the project, the mechanisms by which it has been extended, and some of the challenges being addressed as it evolves. We also discuss the lessons learned through the project, with the aim of enabling researchers &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308634/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308634-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Artificial intelligence-based auto-segmentation programs showed high-quality accuracy and provided standardization and efficient support for guideline-based target volume contouring as a precondition for fully automated workflows in radiotherapy treatment &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309033/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Searches for new physics below twice the electron mass with GERDA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309033-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A search for full energy depositions from bosonic keV-scale dark matter candidates of masses between 65 and 1021 keV has been performed with data collected during Phase II of the GERmanium Detector Array (Gerda) experiment. Our analysis includes direct dark matter absorption as well as dark Compton scattering. With a total exposure of 105.5 kg years, no evidence for a signal above the background has been observed. The resulting exclusion limits deduced with either Bayesian or &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309618/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309618-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: ALKTERNATE revealed feasibility with a novel alternating ALK inhibitor strategy in ALK-positive NSCLC. Results support progressing inquiry into this approach and propose a flexible design with drug(s) selected and alternating time frames, informed by real-time plasma profiling. Moving this concept to treatment naive may also optimize &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309700/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Individual-level determinants of breast and cervical cancer screening and early testing in two regionally representative urban Indian populations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309700-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings may have important implications for interventions at community-level (e.g., reducing &lsquo;fear-of-judgement&rsquo;, increasing awareness to screening programs and early symptoms) and health-system level (e.g., opportunistic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Optimising inter-patient image registration for image-based data mining in breast radiotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: B-spline algorithm using NMI and registered supine and prone cohorts independently provides the most optimal spatial normalisation strategy for breast &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310358/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Surgical Outcomes and Sociodemographic Disparities Across All Races: An ACS-NSQIP and NHIS Multi-Institutional Analysis of Over 7.5 Million Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310358-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study underscores racial disparities in surgical outcomes. Focused investigations into these complications could reveal underlying causes, informing healthcare policies to enhance surgical care &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310744/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310744-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This is the first reported evaluation of the Atellica CI Analyzer in a clinical laboratory setting. The strong analytical performance of the Atellica CI Analyzer demonstrates that this instrument is suitable for routine clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310847/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMxÂ® Digital Spatial Profiler</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310847-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The NanoString GeoMxÂ® DSP platform delivers robust data to interrogate tumor heterogeneity, but tissue storage time should be considered when interpreting the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311030/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Time-resolved photoelectron diffraction imaging of methanol photodissociation involving molecular hydrogen ejection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311030-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Imaging ultrafast atomic and molecular hydrogen motion with femtosecond time resolution is a challenge for ultrafast spectroscopy due to the low mass and small scattering cross section of the moving neutral hydrogen atoms and molecules. Here, we propose time- and momentum-resolved photoelectron diffraction (TMR-PED) as a way to overcome limitations of existing methodologies and illustrate its performance using a prototype molecular dissociation process involving the sequential ejection of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311051/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Is tumour sequencing effective for the identification of germline &lt;em&gt;BRCA1/2&lt;/em&gt; pathogenic variant carriers?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311051-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In our tumour-to-germline testing approach, we observed the BRCA1/2 pathogenic variant frequency reported in other large unselected ovarian cancer cohorts, thus confirming its effectiveness in identifying putative germline carriers irrespective of eligibility for germline testing. As the range of tumours subjected to genetic testing broadens, this approach is expected to also be effective in other tumour settings for enhancing the identification of carriers, reducing the burden &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311115/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">Accessible Weight Scales and Exam Tables - New Federal Regulations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311115-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311116/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">The Role of Physicians on Ethics Committees after &lt;em&gt;Dobbs&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311116-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311134/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">&lt;em&gt;Dobbs&lt;/em&gt; Revisited - Addressing Effects on Resident Training in Obstetrics and Gynecology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311134-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311216/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Indications for testosterone therapy in men</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311216-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Testosterone replacement therapy for men with organic hypogonadism due to medical disease of the hypothalamic-pituitary-testicular (HPT) axis is uncontroversial. In these men, testosterone replacement replaces the deficient hormone and relieves the signs and symptoms of androgen deficiency. In contrast, the role of testosterone treatment in middle-aged or older men who have clinical features consistent with androgen deficiency accompanied by reductions in serum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311249/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">Button-Battery Ingestion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311249-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311354/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Risk Factors and Preventive Measures for Lung Cancer in the European Union</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311354-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Lung cancer is a significant global health challenge. The study identified potential strategies for reducing the mortality rate from lung cancer. These strategies include an increase in the number of physicians, enhanced accessibility to cutting-edge antineoplastic medications, and state-funded coverage of the associated costs. It would be beneficial for politicians to consider implementing LDCT screening for the early detection of the disease. The implementation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311364/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311364-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Driven by technological innovations, newborn screening (NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS are still based on the Wilson and Jungner (WJ) criteria published in 1968. Despite this uniform reference, interpretation of the WJ criteria and actual disease selection for NBS programs are highly variable. A systematic literature search [PubMED search &ldquo;Wilson&rdquo; AND &ldquo;Jungner&rdquo;; last search &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311774/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Telerehabilitation Compared to Center-based Pulmonary Rehabilitation for People with Chronic Respiratory Disease: Economic Analysis of a Randomized, Controlled Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311774-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    RATIONALE: New pulmonary rehabilitation models can improve access to this effective but underutilised treatment for people with chronic respiratory disease, however cost effectiveness has not been &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311864/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Validation of the Late-Life Function and Disability Instrument in People Living with COPD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311864-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The LLFDI, a valid patient-reported outcome to investigate disability and function, has proven good construct validity in people with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311911/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311911-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease-specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312093/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Correction: Prevention at home in older persons with (pre-)frailty: analysis of participants&#39; recruitment and characteristics of the randomized controlled PromeTheus trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312093-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312195/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240923200250&amp;v=2.18.0.post9&#43;e462414">Selective Enhancer Gain of Function Deregulates MYC Expression in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312195-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240923200250-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MYC deregulation occurs in the majority of multiple myeloma (MM) cases and is associated with progression and worse prognosis. Enhanced MYC expression occurs in about 70% of MM patients, but it is known to be driven by translocation or amplification events in only ~40% of myelomas. Here, we used CRISPR interference (CRISPRi) to uncover an epigenetic mechanism of MYC regulation whereby increased accessibility of a plasma cell-type specific enhancer leads to increased MYC expression. This &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312541/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312541-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Findings from our large real-life registry confirm the data from RCTs and extend our knowledge on the effectiveness and safety of DOACs to subjects that were underrepresented in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oyh4uaRSV">å¾ˆå¤šäººåœ¨ç§ä¿¡é‡Œé—®å¦‚ä½•ä¿è¯æ¯å¤©å£æœä¸€æ¬¡å¿…å¦¥ç»´çš„ä¾ä»æ€§ã€‚å…¶å®ä¸å…‰æ˜¯HIVæŠ—ç—…æ¯’è¯ï¼Œæœç”¨å…¶ä»–æ§åˆ¶æ…¢æ€§ç–¾ç—…è¯ç‰©å¦‚é™å‹è¯ã€é™ç³–è¯å’Œè°ƒè¡€è„‚è¯ä¹Ÿéœ€è¦ä¿è¯è‰¯å¥½ä¾ä»æ€§ã€‚æˆ‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyh4uarsv/">
    
    
    
    
    
      
    
    å¾ˆå¤šäººåœ¨ç§ä¿¡é‡Œé—®å¦‚ä½•ä¿è¯æ¯å¤©å£æœä¸€æ¬¡å¿…å¦¥ç»´çš„ä¾ä»æ€§ã€‚å…¶å®ä¸å…‰æ˜¯HIVæŠ—ç—…æ¯’è¯ï¼Œæœç”¨å…¶ä»–æ§åˆ¶æ…¢æ€§ç–¾ç—…è¯ç‰©å¦‚é™å‹è¯ã€é™ç³–è¯å’Œè°ƒè¡€è„‚è¯ä¹Ÿéœ€è¦ä¿è¯è‰¯å¥½ä¾ä»æ€§ã€‚æˆ‘æœ€è¿‘å·¥ä½œä¸­å°±éœ€è¦åˆ†ææ‚£è€…çš„ä¾ä»æ€§æ•°æ®ï¼Œå…¶å®åœ¨ä¸´åºŠä¸Šï¼ŒåŒ»ç”Ÿç›‘æµ‹æ‚£è€…ä¾ä»æ€§ä¹Ÿæ˜¯è®©æ‚£è€…æ•°è¯ç“¶ä¸­çš„è¯ç‰©æ•°é‡ï¼Œä»¥æ­¤æ¥ç›‘æµ‹æ‚£è€…ä¾ä»æ€§ã€‚è¿™é‡Œé™¤äº†æ¯å¤©æœè¯çš„æ—¶å€™ä¸Šé—¹é’Ÿä»¥å¤–ï¼Œè¿˜æœ‰ä¸€ä¸ªå¾ˆå¥½çš„æ–¹æ³•å°±æ˜¯å®æ—¶ç»Ÿè®¡ï¼Œç°åœ¨æœ‰å¾ˆå¤šæœè¯Appå¯ä»¥å¸®åŠ©æ‚£è€…ç›‘æµ‹ä¾ä»æ€§ï¼Œè¿™äº›Appæœ‰æ¯å¤©æé†’åŠŸèƒ½ï¼Œä¹Ÿæœ‰è¯ç‰©æ•°é‡ç›‘æµ‹åŠŸèƒ½ã€‚é™¤æ­¤ä»¥å¤–ï¼Œä¸€ä¸ªå¾ˆå¥½çš„åŠæ³•æ˜¯å¯ä»¥å»ºç«‹ä¸€ä¸ªexcelè¡¨æ ¼ï¼Œåœ¨æ¯ä¸€æ®µæ—¶é—´ï¼Œæ›´æ–°è¯ç“¶é‡Œçš„è¯ç‰©æ•°é‡ï¼Œä»¥æ­¤æ¥ç›‘æµ‹ä¾ä»æ€§ã€‚å¦‚æœä»Šå¤©å¿˜è®°è‡ªå·±æ˜¯å¦æœè¯ï¼Œå¯ä»¥çœ‹è¡¨æ ¼ä¸­è¯ç‰‡æ•°é‡å’Œè‡ªå·±å®é™…è¯ç“¶æ•°é‡ä¸­æ˜¯å¦æœ‰å·® &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OynLRkMnT">æˆ‘ä¸çŸ¥é“ä½ ä»¬ä¸ºä»€ä¹ˆè€åš·åš·ä»€ä¹ˆæˆå»ºåˆ¶ç¾å›½æ¢çš®ä»€ä¹ˆçš„â€¦â€¦æƒ³è±¡ä¸å‡ºé ç¾å†›çš„æ‹›å‹Ÿä½“ç³»å’Œå†›äº‹çºªå¾‹æ€ä¹ˆæ”¯æ’‘ä½ ä»¬è¿™æ ·çš„æƒ³æ³•ã€‚//@æ‘è¾¹ä¸¤æ¡æ²³:ä»¥è‰²åˆ—åš·åš·äº†é‚£ä¹ˆé•¿æ—¶é—´çš„åŒ—...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oynlrkmnt/">
    
    
    
    
    
      
    
    æˆ‘ä¸çŸ¥é“ä½ ä»¬ä¸ºä»€ä¹ˆè€åš·åš·ä»€ä¹ˆæˆå»ºåˆ¶ç¾å›½æ¢çš®ä»€ä¹ˆçš„â€¦â€¦æƒ³è±¡ä¸å‡ºé ç¾å†›çš„æ‹›å‹Ÿä½“ç³»å’Œå†›äº‹çºªå¾‹æ€ä¹ˆæ”¯æ’‘ä½ ä»¬è¿™æ ·çš„æƒ³æ³•ã€‚//<!-- raw HTML omitted -->@æ‘è¾¹ä¸¤æ¡æ²³<!-- raw HTML omitted -->:ä»¥è‰²åˆ—åš·åš·äº†é‚£ä¹ˆé•¿æ—¶é—´çš„åŒ—ä¼ï¼Œä¸€ç›´æ‹–åˆ°ç°åœ¨æ‰è¡ŒåŠ¨ï¼ŒèƒŒåè‚¯å®šæœ‰é˜´è°‹çš„ï¼Œä¸€æ–¹é¢æ˜¯é’ˆå¯¹é»å·´å«©çš„ä¿¡æ¯æœé›†å’Œæš—æ€è¡ŒåŠ¨ã€‚å¦ä¸€æ‰‹å‡†å¤‡ææœ‰å¯èƒ½æ˜¯è·Ÿç¾å›½çš„æ¢çš®éƒ¨é˜Ÿåœ¨è¿›è¡Œè”åˆä½œæˆ˜è®­ç»ƒï¼ŒåŸæ¥ä¸€ä¸ªå¸ˆçš„äººå‘˜ä¸ç«åŠ›å…ˆï¼Œç°åœ¨æœ‰å¯èƒ½å˜æˆä¸€ä¸ªé›†å›¢å†›<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ä»¥è‰²åˆ—å›½é˜²å†›æ€»å‚è°‹é•¿èµ«å°”é½Â·å“ˆå‹’ç»´ä¸­å°†è¡¨ç¤ºï¼Œâ€œä»¥è‰²åˆ—å†›æ–¹æ­£åœ¨ç“¦è§£çœŸä¸»å…š 20 å¹´æ¥å»ºç«‹èµ·æ¥çš„èƒ½åŠ›ã€‚â€<!-- raw HTML omitted -->ğŸ”»â€¦â€¦ä¸æ˜¯ï¼Œä½ è¿å—é»ä¸‰å…«çº¿çº§åˆ«çš„åœ°ä¸‹å·¥äº‹ç¾¤è¾¹éƒ½æ²¡æŒ¨ç€ï¼Œæè¿™å„¿å¹ç‰›æ‰¹å¯è¿˜è¡Œï¼Ÿéª—äººéª—å·±ï¼Œèƒ½éª—å¾—äº†æˆ‘ä»¬ä¸œäºšæ€ªç‰©æˆ¿ä¹ˆï¼Ÿ<!-- raw HTML omitted -->ğŸ”»via &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyo5wf6pG">ğŸ”»ç°åœ¨æ²¡æœ‰ç¡çš„åŸå› æ˜¯ä¸€è¾¹åˆ·é»ä»¥å¯¹è½°ï¼Œä¸€è¾¹åˆ·æŸæ¼«ç”»å·¥ä½œå®¤å‘˜å·¥å‰å‘˜å·¥å¯¹è½°[å“†å•¦Aæ¢¦åƒæƒŠ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyo5wf6pg/">
    
    
    
    
    
      
    
    ğŸ”»ç°åœ¨æ²¡æœ‰ç¡çš„åŸå› æ˜¯ä¸€è¾¹åˆ·é»ä»¥å¯¹è½°ï¼Œä¸€è¾¹åˆ·æŸæ¼«ç”»å·¥ä½œå®¤å‘˜å·¥å‰å‘˜å·¥å¯¹è½°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyo9Cmr5H">ğŸ”»#æä¹é¸Ÿå·¥ä½œå®¤#è¿™ç“œåƒçš„æˆ‘ç¡æ„å…¨æ— [å“†å•¦Aæ¢¦åƒæƒŠ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyo9cmr5h/">
    
    
    
    
    
      
    
    ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted -->#æä¹é¸Ÿå·¥ä½œå®¤#<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™ç“œåƒçš„æˆ‘ç¡æ„å…¨æ— <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyoa6dbCn">é»å·´å«©al-mã€å¡å¡”å°”ajaã€è·¯é€ç¤¾ã€ä»¥è‰²åˆ—æ—¶æŠ¥å’Œæ–°æ¶ˆæ¯æŠ¥è¿™å‡ å®¶åª’ä½“å®˜ç½‘éƒ½å¼€äº†æ–°é—»liveæ¨¡å¼ã€‚//@Astanian:åœ¨ ä»€ä¹ˆç½‘ç«™åˆ·é»å·´å«©ä»¥è‰²åˆ—å¯¹è½°çš„å•Šï¼Ÿ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoa6dbcn/">
    
    
    
    
    
      
    
    é»å·´å«©al-mã€å¡å¡”å°”ajaã€è·¯é€ç¤¾ã€ä»¥è‰²åˆ—æ—¶æŠ¥å’Œæ–°æ¶ˆæ¯æŠ¥è¿™å‡ å®¶åª’ä½“å®˜ç½‘éƒ½å¼€äº†æ–°é—»liveæ¨¡å¼ã€‚//<!-- raw HTML omitted -->@Astanian<!-- raw HTML omitted -->:åœ¨ ä»€ä¹ˆç½‘ç«™åˆ·é»å·´å«©ä»¥è‰²åˆ—å¯¹è½°çš„å•Šï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ç°åœ¨æ²¡æœ‰ç¡çš„åŸå› æ˜¯ä¸€è¾¹åˆ·é»ä»¥å¯¹è½°ï¼Œä¸€è¾¹åˆ·æŸæ¼«ç”»å·¥ä½œå®¤å‘˜å·¥å‰å‘˜å·¥å¯¹è½°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyoe27Q8G">ğŸ”»ç›®å‰å°±çœ‹åˆ°@æä¹é¸Ÿ-çˆ±ç”»ç”» å’Œå¦ä¸€ä½å‡ºæ¥å›åº”äº†ä¸€å¤§å †ã€‚ğŸ”»å¦å¤–ä¸€è¾¹å‚ä¸å£°è®¨çš„å‰å‘˜å·¥ä¹Ÿæœ‰ä¸å°‘ã€‚ğŸ”»æ€ä¹ˆè®²â€¦â€¦è¿™ç“œåƒçš„å¿ƒæƒ…æœ‰ç‚¹å¤æ‚[å“†å•¦Aæ¢¦åƒæƒŠ]ã€‚#æä¹é¸Ÿ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoe27q8g/">
    
    
    
    
    
      
    
    ğŸ”»ç›®å‰å°±çœ‹åˆ°<!-- raw HTML omitted -->@æä¹é¸Ÿ-çˆ±ç”»ç”»<!-- raw HTML omitted --> å’Œå¦ä¸€ä½å‡ºæ¥å›åº”äº†ä¸€å¤§å †ã€‚<!-- raw HTML omitted -->ğŸ”»å¦å¤–ä¸€è¾¹å‚ä¸å£°è®¨çš„å‰å‘˜å·¥ä¹Ÿæœ‰ä¸å°‘ã€‚<!-- raw HTML omitted -->ğŸ”»æ€ä¹ˆè®²â€¦â€¦è¿™ç“œåƒçš„å¿ƒæƒ…æœ‰ç‚¹å¤æ‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5%B7%A5%E4%BD%9C%E5%AE%A4%23&amp;amp;extparam=%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5%B7%A5%E4%BD%9C%E5%AE%A4%23&amp;amp;extparam=%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyokehgc5">ğŸ”»ä¸ºäº†æ–¹ä¾¿å¤§å®¶åŠå¤œåƒç“œï¼Œæˆ‘æŠŠå‡ ä¸ªå½“äº‹äººæœ€é‡è¦çš„å‡ æ¡å¾®åšæ•´åˆåœ¨è¿™é‡Œï¼šğŸ”»@çœŸ-æŸ³å ¡ çš„å…³é”®å‡ ç¯‡åœ¨å›¾1-å›¾4ğŸ”»@A-souléŸ©è¶… çš„å›åº”åœ¨å›¾5-7ğŸ”»@æä¹é¸Ÿ-çˆ±ç”»ç”» çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyokehgc5/">
    
    
    
    
    
      
    
    ğŸ”»ä¸ºäº†æ–¹ä¾¿å¤§å®¶åŠå¤œåƒç“œï¼Œæˆ‘æŠŠå‡ ä¸ªå½“äº‹äººæœ€é‡è¦çš„å‡ æ¡å¾®åšæ•´åˆåœ¨è¿™é‡Œï¼š<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->@çœŸ-æŸ³å ¡<!-- raw HTML omitted --> çš„å…³é”®å‡ ç¯‡åœ¨å›¾1-å›¾4<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->@A-souléŸ©è¶…<!-- raw HTML omitted --> çš„å›åº”åœ¨å›¾5-7<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->@æä¹é¸Ÿ-çˆ±ç”»ç”»<!-- raw HTML omitted --> çš„å›åº”åœ¨å›¾8<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->@æ¶è‡­ç”Ÿé²œ<!-- raw HTML omitted --> çš„å›åº”åœ¨å›¾9<!-- raw HTML omitted -->ğŸ”»è¿˜æœ‰ä¸€äº›å‰å‘˜å·¥çš„å‘è¨€åœ¨ç›¸å…³å¾®åšè¯„è®ºåŒº<!-- raw HTML omitted -->ğŸ”»ä½œä¸ºè·¯äººï¼Œæˆ‘çœ‹å®Œä¹‹åä»ä¸çŸ¥è°å¯¹è°é”™ï¼Œä½œä¸ºA-soulè¯¸å¤šä½œå“å’Œä¸­å›½å›½äº§æ¼«ç”»ä»ç”»ç‹æ—¶ä»£å°±ä¸€å¦‚æ—¢å¾€æ”¯æŒã€å…³æ³¨çš„è¯»è€…ï¼Œæˆ‘çœ‹å®Œä¹‹åå¿ƒæƒ…å¤æ‚ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™ä¸ªå¤æ‚ä¸ä»…ä»…æ˜¯å› ä¸ºè¿™ä¸ªç“œçš„ï¼Œè¿˜æœ‰å…³äºè¿™ä¸ªè¡Œä¸šç‡ƒçƒ§äº†ä¸çŸ¥é“å¤šå°‘äººçš„çƒ­çˆ±å’Œé’æ˜¥çš„ã€‚<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyomUBIAl">ğŸ”»æˆ‘ä¸çŸ¥é“è¿™ä¸ªæ¯”å–»å¯¹ä¸å¯¹ã€‚å°±æœ‰ä¸€ç‚¹ç‚¹åƒçœ‹äº”é»‘æ¡†çš„æ„Ÿè§‰ã€‚#æä¹é¸Ÿå·¥ä½œå®¤#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyomubial/">
    
    
    
    
    
      
    
    ğŸ”»æˆ‘ä¸çŸ¥é“è¿™ä¸ªæ¯”å–»å¯¹ä¸å¯¹ã€‚å°±æœ‰ä¸€ç‚¹ç‚¹åƒçœ‹äº”é»‘æ¡†çš„æ„Ÿè§‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æä¹é¸Ÿå·¥ä½œå®¤#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyop30OPa">é—®çš„å¥½ï¼Œè¿™ä¸ªè¡Œä¸šçš„æ— æ•°åœºæ’•é€¼ï¼Œå¤§éƒ½æºäºæ­¤//@æ¡ƒå­å±å±å°é¦’å¤´:è¿™ä¸ªè¡Œä¸šç‡ƒçƒ§äº†ä¸çŸ¥é“å¤šå°‘äººçš„çƒ­çˆ±å’Œé’æ˜¥ï¼Œæ—¢å¾—åˆ©ç›Šè€…åˆ°åº•æ˜¯è°å‘¢ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ï¿½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyop30opa/">
    
    
    
    
    
      
    
    é—®çš„å¥½ï¼Œè¿™ä¸ªè¡Œä¸šçš„æ— æ•°åœºæ’•é€¼ï¼Œå¤§éƒ½æºäºæ­¤//<!-- raw HTML omitted -->@æ¡ƒå­å±å±å°é¦’å¤´<!-- raw HTML omitted -->:è¿™ä¸ªè¡Œä¸šç‡ƒçƒ§äº†ä¸çŸ¥é“å¤šå°‘äººçš„çƒ­çˆ±å’Œé’æ˜¥ï¼Œæ—¢å¾—åˆ©ç›Šè€…åˆ°åº•æ˜¯è°å‘¢<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ä¸ºäº†æ–¹ä¾¿å¤§å®¶åŠå¤œåƒç“œï¼Œæˆ‘æŠŠå‡ ä¸ªå½“äº‹äººæœ€é‡è¦çš„å‡ æ¡å¾®åšæ•´åˆåœ¨è¿™é‡Œï¼š<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->@çœŸ-æŸ³å ¡<!-- raw HTML omitted --> çš„å…³é”®å‡ ç¯‡åœ¨å›¾1-å›¾4<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->@A-souléŸ©è¶…<!-- raw HTML omitted --> çš„å›åº”åœ¨å›¾5-7<!-- raw HTML omitted -->ğŸ”»&lt;a href=&ldquo;<a href="https://weibo.com/n/%E6%9E%81%E4%B9%90%E9%B8%9F-%E7%88%B1%E7%94%BB%25E">https://weibo.com/n/%E6%9E%81%E4%B9%90%E9%B8%9F-%E7%88%B1%E7%94%BB%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyosKAop0">ğŸ”»æ›¾ç»ï¼Œwowçš„é¦–æ€å›¢å¥½åƒä¹Ÿå‡ºè¿‡ç±»ä¼¼çš„äº‹æƒ…â€¦â€¦ğŸ”»æˆ‘å¯¹é‚£ä¸ªå°é•‡ä¸Šçš„å·¥ä½œå®¤ä¹Ÿè®°å¿†çŠ¹æ–°ã€‚#æä¹é¸Ÿå·¥ä½œå®¤#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoskaop0/">
    
    
    
    
    
      
    
    ğŸ”»æ›¾ç»ï¼Œwowçš„é¦–æ€å›¢å¥½åƒä¹Ÿå‡ºè¿‡ç±»ä¼¼çš„äº‹æƒ…â€¦â€¦<!-- raw HTML omitted -->ğŸ”»æˆ‘å¯¹é‚£ä¸ªå°é•‡ä¸Šçš„å·¥ä½œå®¤ä¹Ÿè®°å¿†çŠ¹æ–°ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æä¹é¸Ÿå·¥ä½œå®¤#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyph9p4Ns">ğŸ”»é»å·´å«©å«ç”Ÿéƒ¨ï¼šä»¥å†›å½“å¤©å¯¹é»å·´å«©å¤šåœ°å‘åŠ¨ç©ºè¢­é€ æˆçš„æ­» äº¡äººæ•°å‡è‡³492äººï¼Œå¦æœ‰1645äººå—ä¼¤ã€‚ğŸ”»å›¾ä¸ºé»å·´å«©åª’ä½“å…¬å¸ƒçš„éƒ¨åˆ†é‡ éš¾ è€…ã€‚#ä»¥å†›ç©ºè¢­é»å·´å«©å¤šåœ°è‡´275...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyph9p4ns/">
    
    
    
    
    
      
    
    ğŸ”»é»å·´å«©å«ç”Ÿéƒ¨ï¼šä»¥å†›å½“å¤©å¯¹é»å·´å«©å¤šåœ°å‘åŠ¨ç©ºè¢­é€ æˆçš„æ­» äº¡äººæ•°å‡è‡³492äººï¼Œå¦æœ‰1645äººå—ä¼¤ã€‚<!-- raw HTML omitted -->ğŸ”»å›¾ä¸ºé»å·´å«©åª’ä½“å…¬å¸ƒçš„éƒ¨åˆ†é‡ éš¾ è€…ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥å†›ç©ºè¢­é»å·´å«©å¤šåœ°è‡´275æ­»1024ä¼¤#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbgy1htyd2jzz2tj20zu12vwmc.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbgy1htyd2jzz2tj20zu12vwmc.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OykeUzfHd">éåº¦åŠªåŠ›æœ‰å®³å¥åº·çš„[æ³ª] - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.09.22 20:29ã€Œæ¬¸å˜¿å˜¿ã€å‘œå“‡å“‡ï½æ¯å¤©éƒ½åœ¨åŠªåŠ›è™½ç„¶æœ‰æ—¶å€™æœ‰ç‚¹è¿‡åº¦åŠªåŠ›äº†ä½†æ˜¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oykeuzfhd/">
    
    
    
    
    
      
    
    éåº¦åŠªåŠ›æœ‰å®³å¥åº·çš„<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/201">https://n.sinaimg.cn/photo/5213b46e/201</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OylW7xnJb">ä¹…ä¿å²ç»ªé‡Œ via.ä¹ƒæœ¨æ‹ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oylw7xnjb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.ä¹ƒæœ¨æ‹ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1htxyd4qjjbj30hs0nqair.jp">https://tvax2.sinaimg.cn/large/006z6nxLgy1htxyd4qjjbj30hs0nqair.jp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oymgag7vp">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.09.23 16:21ã€Œå¥½å˜ã€æ—©ä¸Šå¥½ä»æ—©ä¸Šå°±å¼€å§‹åŠªåŠ›å•¦æœ€è¿‘æ„Ÿè§‰æ€»åœ¨å¬ãƒãƒ¼ãƒˆãƒ‡ã‚¤ã€‚ä¼¼ä¹æ˜¯å› ä¸ºç§‹å¤©çš„æ¥ä¸´æ„Ÿåˆ°ä¸èˆã€‚ã€‚è™½ç„¶è¿™ä¹ˆè¯´ï¼Œä¼¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oymgag7vp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%B</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

